Seres Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2015 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Seres Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2015 to Q3 2024.
  • Seres Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 171M shares, a 32.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 171M +41.5M +32.1% Nov 8, 2024 10-Q 2024-11-13
Q2 2024 152M +23.5M +18.4% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 151M +24.9M +19.8% Mar 1, 2024 10-K 2024-03-05
Q3 2023 129M +4.67M +3.75% Oct 30, 2023 10-Q 2023-11-02
Q2 2023 128M +4.13M +3.33% Aug 4, 2023 10-Q 2023-08-08
Q1 2023 126M +33.8M +36.7% Mar 3, 2023 10-K 2023-03-07
Q3 2022 125M +32.7M +35.7% Oct 28, 2022 10-Q 2022-11-02
Q2 2022 124M +32.4M +35.3% Aug 1, 2022 10-Q 2022-08-03
Q1 2022 92.2M +608K +0.66% Apr 27, 2022 10-Q 2022-05-04
Q3 2021 91.8M +599K +0.66% Nov 3, 2021 10-Q 2021-11-10
Q2 2021 91.7M +15.5M +20.3% Jul 28, 2021 10-Q 2021-08-03
Q1 2021 91.6M +19M +26.2% Apr 28, 2021 10-Q 2021-05-04
Q3 2020 91.2M +21.3M +30.4% Nov 3, 2020 10-Q 2020-11-09
Q2 2020 76.3M +6.35M +9.08% Jul 22, 2020 10-Q 2020-07-28
Q1 2020 72.6M +31.5M +76.7% May 1, 2020 10-Q 2020-05-07
Q3 2019 70M +29.1M +71.3% Oct 29, 2019 10-Q 2019-11-05
Q2 2019 69.9M +29.1M +71.4% Jul 31, 2019 10-Q 2019-08-06
Q1 2019 41.1M +446K +1.1% Apr 24, 2019 10-Q 2019-05-02
Q3 2018 40.9M +326K +0.8% Nov 2, 2018 10-Q 2018-11-08
Q2 2018 40.8M +283K +0.7% Jul 26, 2018 10-Q 2018-08-02
Q1 2018 40.6M +280K +0.69% Mar 2, 2018 10-K 2018-03-08
Q3 2017 40.5M +174K +0.43% Nov 3, 2017 10-Q 2017-11-08
Q2 2017 40.5M +238K +0.59% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 40.4M +1.18M +3.01% Mar 10, 2017 10-K 2017-03-16
Q3 2016 40.4M +1.3M +3.33% Nov 7, 2016 10-Q 2016-11-10
Q2 2016 40.3M +1.31M +3.36% Aug 5, 2016 10-Q 2016-08-11
Q1 2016 39.2M Mar 7, 2016 10-K 2016-03-14
Q3 2015 39.1M Nov 6, 2015 10-Q 2015-11-12
Q2 2015 39M Aug 7, 2015 10-Q 2015-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.